Prostatis Group’s Invesco S&P 500 High Beta ETF SPHB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-51,723
Closed -$4.54M 157
2024
Q1
$4.54M Sell
51,723
-27,490
-35% -$2.28M 1.72% 14
2023
Q4
$6.53M Buy
+79,213
New +$5.71M 2.73% 7

Other funds holding SPHB

Prostatis Group's SPHB Position: Q2 2024 in Review

Prostatis Group sold out of Invesco S&P 500 High Beta ETF (SPHB) in Q2 2024, closing a stake of 51,723 shares — an estimated $4.54M sold.

Prostatis Group first reported a position in SPHB in Q4 2023 and held it in 2 quarters. The position peaked at $6.53M in Q4 2023. 125 funds tracked by Wall St. Rank hold SPHB as of Q2 2024.

  • Prostatis Group reported no remaining Invesco S&P 500 High Beta ETF position as of Q2 2024 after selling out during the quarter.
  • Prostatis Group sold 51,723 Invesco S&P 500 High Beta ETF shares in Q2 2024, an estimated $4.54M.
  • Prostatis Group first reported a position in Invesco S&P 500 High Beta ETF in Q4 2023 and held it in 2 quarters.
  • Prostatis Group's Invesco S&P 500 High Beta ETF position peaked at $6.53M in Q4 2023.
  • 125 funds tracked by Wall St. Rank held Invesco S&P 500 High Beta ETF as of Q2 2024.

Based on Prostatis Group's 13F filing for Q2 2024, filed 21 Mar 2025.